Explore Products
Primary Cells

Human Diffuse Large B-Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

  • BSL

    1

  • 142
Diffuse Large B-Cell Lymphoma PBMCs are density separated using Ficoll-Paque. Diffuse Large B-Cell Lymphoma Peripheral Blood Mononuclear Cells are available in the untreated and relapsed/refractory stages.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC3406

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Diffuse Large B-Cell Lymphoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Diffuse Large B-Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated) are derived from the peripheral blood of patients with newly diagnosed but untreated diffuse large B-cell lymphoma (DLBCL). Tumor B cells often harbor chromosomal abnormalities including translocations involving BCL6, MYC, or BCL2 detected by cytogenetic or FISH analysis.They are enriched by density gradient centrifugation, often accompanied by co-isolation of tumor B cells and reactive immune cells (T cells, NK cells, monocytes). High expression of B cell markers CD19, CD20; activated B-cell markers MUM1; germinal center markers BCL6; and proliferation markers such as Ki-67.Morphologically, these cells are highly heterogeneous. They carry rearranged immunoglobulin genes (IGH/IGK/IGL), highly express activated B cells or germinal center B cell subtype characteristic molecules (such as MUM1, BCL6), continue to proliferate through pathways such as NF-κB, PI3K/AKT, and secrete factors such as IL-10 and CXCL13 to reshape the immune microenvironment.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Diffuse Large B-Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated) provides an important tool for analyzing DLBCL tumor heterogeneity, immune escape mechanisms, and resistance to targeted therapies (such as BTK inhibitors, PD-1/PD-L1 blockers), especially for longitudinal cohort analysis of newly diagnosed patient samples.

Inquiring Human Diffuse Large B-Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button